GINWA(SH:600080) Xin Lang Cai Jing·2025-10-20 06:35Core Viewpoint - Jinhua Co., Ltd. has experienced a slight increase in stock price recently, with a year-to-date decline, indicating potential volatility in the market [1][2]. Company Overview - Jinhua Co., Ltd. is located in Xi'an, Shaanxi Province, established on February 14, 1996, and listed on June 12, 1997. The company primarily engages in the research, production, and sales of pharmaceuticals, with 99.71% of its revenue coming from drug sales [2]. - The company operates within the pharmaceutical and biotechnology sector, specifically in traditional Chinese medicine [2]. Financial Performance - For the first half of 2025, Jinhua Co., Ltd. reported a revenue of 241 million yuan, a year-on-year decrease of 1.90%, and a net profit attributable to shareholders of 6.195 million yuan, down 34.53% year-on-year [2]. - The company has distributed a total of 118 million yuan in dividends since its A-share listing, with 10.5814 million yuan distributed over the past three years [3]. Stock Performance - The stock price of Jinhua Co., Ltd. has decreased by 1.95% year-to-date, but has seen a recent uptick of 4.95% over the last five trading days [2]. - As of October 20, the stock was trading at 7.63 yuan per share, with a market capitalization of 2.848 billion yuan [1].